KOL Knockout™ Retina Edition

Table of Contents

This activity is supported by unrestricted educational grants from Bausch + Lomb and Genentech, a Roche company.

January/February 2023 Supplement

KOL Knockout™ Retina Edition

Experts go toe to toe on medical and surgical treatment approaches.

Share:

January/February 2023 Supplement cover

View Supplement